Literature DB >> 27095100

Neuralgic amyotrophy associated with hepatitis E virus (HEV) infection: a case report.

Michela Bisciglia1, Peter Van den Bergh2, Thierry Duprez3, Benoit Mukadi Kabamba4, Adrian Ivanoiu2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27095100     DOI： 10.1007/s13760-016-0642-1

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN： 0300-9009            Impact factor:   2.396


× No keyword cloud information.
  6 in total

Review 1.  Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections.

Authors:  Sarah Jacob; Ronak Kapadia; Tyler Soule; Honglin Luo; Kerri L Schellenberg; Renée N Douville; Gerald Pfeffer
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

2.  Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient.

Authors:  A Velay; W Kack-Kack; F Abravanel; S Lhomme; P Leyendecker; L Kremer; P Chamouard; J Izopet; S Fafi-Kremer; H Barth
Journal:  J Neurovirol       Date:  2017-04-24       Impact factor: 2.643

Review 3.  Neuralgic amyotrophy triggered by hepatitis E virus: a particular phenotype.

Authors:  Quentin Scanvion; Thierry Perez; François Cassim; Olivier Outteryck; Aurélia Lanteri; Pierre-Yves Hatron; Marc Lambert; Sandrine Morell-Dubois
Journal:  J Neurol       Date:  2017-02-28       Impact factor: 6.682

4.  Neuralgic amyotrophy: an underrecognized entity.

Authors:  Tae Uk Kim; Min Cheol Chang
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

5.  Parsonage-Turner Syndrome as a Rare Extrahepatic Complication of Hepatitis E Infection.

Authors:  Claude Ngah Njabom; Allison Gilbert; Edmond Brasseur; Régine Zandona; Alexandre Ghuysen; Vincent D'Orio
Journal:  Eur J Case Rep Intern Med       Date:  2019-08-22

6.  Disseminated inflammation of the central nervous system associated with acute hepatitis E: a case report.

Authors:  Jan Rahmig; Arne Grey; Marco Berning; Jochen Schaefer; Martin Lesser; Heinz Reichmann; Volker Puetz; Kristian Barlinn; Timo Siepmann
Journal:  BMC Neurol       Date:  2020-10-27       Impact factor: 2.474
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.